FDA, USPTO Set January Date For Public Input On Competition
The public will be allowed to offer comments at a January meeting between federal patent and drug officials about their joint efforts on furthering competition, the latest collaboration between the parties...To view the full article, register now.
Already a subscriber? Click here to view full article